Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

NIH - National Institutes of Health National Cancer Institute Division of Cancer Treatment and Diagnosis Center for Cancer Research
NCI Experimental Therapeutics Program (NExT)
Contact NExT
Show menu
Search this site
Last Updated: 10/03/19

Preclinical Development Stage NExT Projects

Applicant Institute Project
Brown, Bob Dicerna Pharmaceuticals, Inc. β-catenin/CTNNB1 DsiRNA LNP Therapeutic for HCC and CRC
Markowitz, Sanford Case Western Reserve University SW033291 Markedly Accelerates Tri-Lineage Recovery After Marrow Transplant
Perera, Liyanage National Cancer Institute, Center for Cancer Research, NIH CARs targeting the chemokine receptor CCR4 as a therapeutic modality for T-cell leukemias
Rittenhouse-Olson, Kate For-Robin, Inc hJAA-F11, a Humanized Anti-Thomsen Friedenreich Antibody for Cancer Therapy
Schnitzer, Jan Proteogenomics Research Institute for Systems Medicine Developing hAnnA1-based immunoconjugates for cancer detection and treatment